Apósito antibacteriano con violeta de genciana y azul de metileno en úlceras crónicas infectadas
References
1. Woo KY, Heil J. A prospective evaluation of methylene blue and gentian violet dressing for management of chronic wounds with local infection. Int Wound J. 2017; 14(6): 1029-1035.
2. Lullove EJ. Use of Ovine-based Collagen Extracellular Matrix and Gentian Violet/Methylene Blue Antibacterial Foam Dressings to Help Improve Clinical Outcomes in Lower Extremity Wounds: A Retrospective Cohort Study. Wounds. 2017; 29(4): 107-114.
3. Applewhite AJ, Attar P, Liden B, Stevenson Q. Gentian Violet and Methylene Blue Polyvinyl Alcohol Foam Antibacterial Dressing as a Viable Form of Autolytic Debridement in the Wound Bed. Surg Technol Int. 2015; 26: 65-70.
4. Coutts PM, Ryan J, Sibbald RG. Case series of lower-extremity chronic wounds managed with an antibacterial foam dressing bound with gentian violet and methylene blue. Adv Skin Wound Care. 2014; 27(3 Suppl 1): 9-13.
2. Lullove EJ. Use of Ovine-based Collagen Extracellular Matrix and Gentian Violet/Methylene Blue Antibacterial Foam Dressings to Help Improve Clinical Outcomes in Lower Extremity Wounds: A Retrospective Cohort Study. Wounds. 2017; 29(4): 107-114.
3. Applewhite AJ, Attar P, Liden B, Stevenson Q. Gentian Violet and Methylene Blue Polyvinyl Alcohol Foam Antibacterial Dressing as a Viable Form of Autolytic Debridement in the Wound Bed. Surg Technol Int. 2015; 26: 65-70.
4. Coutts PM, Ryan J, Sibbald RG. Case series of lower-extremity chronic wounds managed with an antibacterial foam dressing bound with gentian violet and methylene blue. Adv Skin Wound Care. 2014; 27(3 Suppl 1): 9-13.
Downloads
Published
2020-06-10
How to Cite
1.
Martínez Pizarro S. Apósito antibacteriano con violeta de genciana y azul de metileno en úlceras crónicas infectadas. Rev 16 de abril [Internet]. 2020 Jun. 10 [cited 2024 Dec. 12];59(277):e903. Available from: https://rev16deabril.sld.cu/index.php/16_04/article/view/903
Issue
Section
Letter to the Editor
License
Those authors who have publications with this journal, accept the following terms:
The authors will retain their copyright and guarantee the journal the right of first publication of your work, which will be under a Creative license Commons Attribution-NonCommercial-ShareAlike 4.0 International . (CC BY-NC-SA 4.0).
The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (eg:deposit it in an institutional telemat
